Clinical trial
Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial
NCT05695521 is registered in ClinicalTrials.gov with Cellenkos, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial
- Lead sponsor
- Cellenkos, Inc.
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- April 3, 2023
- Completion date
- December 31, 2027
- Enrollment
- 66 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.